For security purposes
FOR SECURITY PURPOSES - because Internet Explorer is no longer supported by Microsoft, we suggest that you interact with our secure site through one of our supported browsers - Google Chrome, Firefox, or MS Edge. If you continue to use this website with Internet Explorer you do so at your own risk and you may encounter problems.
Documents
Ph. Eur. Monograph 2423: Valsartan Related Substances with Ph. Eur. Method Modernization (AN-1160)
This application note demonstrates the potential method improvements that can be achieved within the allowed adjustments of chromatographic conditions. Different dimensions of a Luna™ Omega C18 column were used for evaluating the related substances method, within the new allowable adjustments published by European Pharmacopeia, Chapter 2.2.46, updated July 2022.

Ph. Eur. Monograph 2423: Valsartan Related Substances with Ph. Eur. Method Modernization (AN-1160)

This application note demonstrates the potential method improvements that can be achieved within the allowed adjustments of chromatographic conditions. Different dimensions of a Luna™ Omega C18 column were used for evaluating the related substances method, within the new allowable adjustments published by European Pharmacopeia, Chapter 2.2.46, updated July 2022.
Document Type:
Technical Notes
Target Industries:
Brands:
Separation Modes:
Reversed Phase